Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining

Bethany L Tiner1, Jian Sha2, Michelle L Kirtley1

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Infection and Immunity
|January 22, 2015
PubMed

Insights

Deleting the ail gene from Yersinia pestis CO92, alongside Lpp and MsbB deletions, severely weakened the bacteria. This triple mutant protected mice against pneumonic plague and subsequent challenge, offering a potential vaccine candidate.

Area of Science:

  • Microbiology and Immunology
  • Infectious Diseases
  • Vaccine Development

Background:

  • Yersinia pestis causes plague; previous studies attenuated it by deleting Braun lipoprotein (Lpp) and MsbB genes.
  • Lpp activates Toll-like receptor 2, while MsbB modifies lipopolysaccharide, both key bacterial components.

Purpose of the Study:

  • To investigate the effect of deleting the attachment-invasion locus (ail) gene from Yersinia pestis CO92, individually and in combination with Lpp and MsbB deletions.
  • To evaluate the resulting mutant's attenuation, immunogenicity, and protective potential against pneumonic plague in a mouse model.

Main Methods:

  • Genetic manipulation of Yersinia pestis CO92 to create single, double, and triple mutants (Δail, Δlpp, ΔmsbB, Δlpp Δail, Δlpp ΔmsbB Δail).
  • Assessment of bacterial attenuation using lethal dose (LD50) determination in a mouse pneumonic plague model.
  • Evaluation of immune responses (antibody isotyping, cytokine production) and bacterial clearance via in vivo imaging and organ burden analysis.
  • In vitro assays examining bacterial adherence, invasion, and intracellular survival in epithelial and macrophage cell lines.
  • Assessment of protection against subsequent challenge with wild-type Yersinia pestis CO92 in surviving mice.

Main Results:

  • The Δlpp ΔmsbB Δail triple mutant was severely attenuated, with an LD50 equivalent to 6,800 LD50s of wild-type CO92.
  • Triple mutant-infected mice showed balanced TH1/TH2 immune responses, rapid bacterial clearance, reduced cytokine production, and fewer lesions.
  • Surviving mice from triple mutant infection were protected against a subsequent challenge with wild-type Yersinia pestis CO92.
  • The triple mutant exhibited decreased adherence, invasion, and intracellular survival in relevant cell lines, and sensitivity to human serum bactericidal activity.

Conclusions:

  • Deletion of the ail gene from the Δlpp ΔmsbB double mutant significantly attenuates Yersinia pestis CO92, rendering it avirulent in a pneumonic plague model.
  • The severely attenuated triple mutant elicits protective immunity against subsequent wild-type Yersinia pestis CO92 challenge, indicating its potential as a live vaccine candidate.
  • The combined genetic modifications enhance bacterial clearance through reduced virulence and improved host immune responses.